Basser, R L <br/><br/>
Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jul 1995 
 - 715-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--pathology<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Hematopoiesis<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Leukapheresis<br/>Leukocyte Count<br/>Lymphatic Metastasis<br/>Middle Aged<br/>Neoplasm Staging<br/>Platelet Count<br/>Recombinant Proteins